D-0324-2026 Class II Ongoing
FDA drug recall D-0324-2026 was initiated by F.H. INVESTMENTS, Inc. (Dba Asteria Health) on Jan 26, 2026 and is designated Class II. Reason for recall: Presence of Foreign substance - potential presence of metal particulate matter The recall status is ongoing. Affected quantity: 194,336 pellets.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 18, 2026
- Initiation Date
- Jan 26, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 194,336 pellets
Product description
Testosterone, 200 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1200-43.
Reason for recall
Presence of Foreign substance - potential presence of metal particulate matter
Distribution pattern
Nationwide in the USA
Code information
Lot#: 251000127, Exp. 06/03/2026; 251000128, Exp. 06/05/2026; 251000133, 251000134, 251000135, Exp. 06/16/2026; 251000138, 251000139, 251000140, 251000141, Exp. 06/25/2026; 251000147, 251000148, 251000149, Exp. 07/28/2026; 251000156, 251000157, Exp. 08/08/2026; 251000164, 251000165, 251000166, Exp. 08/22/2026; 251000169, Exp. 08/29/2026; 251000171, 251000172, Exp. 09/03/2026; 251000180, Exp. 09/19/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0324-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026